Skip to main content

Table 1 Clinical parameters of Kawasaki disease patients

From: Activin a suppresses peripheral CD8+ T lymphocyte activity in acute-phase Kawasaki disease

Sex

KD1

KD2

KD3

KD4

KD5

KD6

KD7

Male

Male

Male

Male

Female

Female

Female

Age(y)

3.92

1.25

1.75

2.17

1.17

1.50

1.75

WBC(109/L)

22.67

9.18

12.31

21.78

28.34

20.54

17.76

RBC(1012/L)

4.19

4.56

4.24

3.91

3.96

4.03

3.94

Hemoglobin(g/L)

116

116

114

109

105

104

97

PLT (109/L)

535

370

565

602

527

457

454

CRP (mg/L)

67.7

99.8

12.56

174.97

78.7

35.4

37

TBil (umol/L)

5.8

12.5

4.2

10.2

4.7

7.9

4.2

ALT (IU/L)

529

27

12

32

68

14

21

AST (IU/L)

131

31

19

21

35

20

23

Sodium (mmol/L)

134.2

126.7

138.9

130

135.6

138.8

136.9

ESR (mm/h)

63

32

46

58

87

90

89

PCT (ng/ml)

1.75

1.95

0.16

1.26

7.38

0.33

0.16

  1. KD Kawasaki disease, y Year, WBC White blood cell counts, RBC Red blood cell counts, PLT Platelet, CRP C-reactive protein, TBil Total bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ESR Erythrocyte sedimentation rate, PCT Procalcitonin